{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:05:07Z","timestamp":1790762707620,"version":"4.1.0"},"reference-count":105,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Breast cancer is still one of the main causes of mortality and morbidity at a global level, highlighting the need to identify robust biomarkers for early diagnosis, prognostic stratification and optimization of therapeutic decisions. Among these biomarkers, HER2 (Human Epidermal Growth Factor Receptor 2) and miR-21 represent the complementary levels of tumor biology, reflecting oncogenic signaling at the protein level and post-transcriptional regulation of gene expression. This hybrid systematic review and bibliometric mapping aims to critically analyze current methods for determining HER2 and miR-21 biomarkers, highlighting their advantages, limitations and clinical applicability, as well as future development directions in the field of precision oncology diagnostics. Methods: The bibliometric analyses were performed to investigate the intellectual structure, research trends, and collaboration patterns within the field of HER2 and miR-21 detection in breast cancer. A PRISMA-guided literature search was conducted in the Web of Science Core Collection (WoSCC), PubMed, and Scopus. After duplicate removal, screening, and eligibility assessment, 305 publications were included in the final review corpus. Bibliometric analyses of these 305 publications were performed using VOSviewer to investigate publication output, keyword co-occurrence, co-authorship, and institutional and country collaboration patterns. Results: Bibliometric analyses revealed the intellectual structure, research trends, and collaboration patterns within the field of HER2 and miR-21 detection in breast cancer. This work highlights the complementary role of HER2 and miR-21 biomarkers in breast cancer, highlighting their fundamental differences, but also their synergistic potential in clinical practice and translational research. A comparative analysis of detection methods highlights that, although conventional techniques remain the clinical standard, they are increasingly complemented by advanced technologies, such as digital PCR, optical and electrochemical biosensors. Conclusions: The emerging detection methods offer significant advantages in terms of sensitivity, rapidity and potential for miniaturization, but their clinical implementation is still limited by the lack of standardization and large-scale validation. A major bibliometric insight is the evident shift in publication output by country toward Asia, particularly China, India, and Iran, which currently show high publication output and extensive collaborative connectivity in the analyzed network. However, challenges remain in standardizing microRNA methods and the clinical validation of emerging technologies.<\/jats:p>","DOI":"10.3390\/diagnostics16193179","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:25:42Z","timestamp":1790760342000},"page":"3179","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Detection Strategies for HER2 and miR-21 in Breast Cancer: Current Approaches and Future Perspectives- Hybrid Systematic Review and Bibliometric Mapping"],"prefix":"10.3390","volume":"16","author":[{"given":"Diana-Maria","family":"Bur\u021ba","sequence":"first","affiliation":[{"name":"Doctoral School of Biological and Biomedical Sciences, \r\n\t  University of Oradea, 1 University Street, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Daniela","family":"Cavalu","sequence":"additional","affiliation":[{"name":"Department of Preclinical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, Pta 1 Decembrie, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luminita","family":"Fritea","sequence":"additional","affiliation":[{"name":"Department of Preclinical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, Pta 1 Decembrie, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tunde","family":"Horvath","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 29 N. Jiga Street, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0040-4737","authenticated-orcid":false,"given":"Sebastian","family":"Nemeth","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 29 N. Jiga Street, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana Aura","family":"Istoan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin","family":"Banica","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 29 N. Jiga Street, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molonc.2012.01.010","article-title":"Cancer biomarkers","volume":"6","author":"Henry","year":"2012","journal-title":"Mol. Oncol."},{"key":"ref_2","first-page":"297","article-title":"Tumour markers","volume":"51","author":"Pandha","year":"1994","journal-title":"Br. J. Hosp. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/jnci\/djq306","article-title":"Cancer biomarkers: Can we turn recent failures into success?","volume":"102","author":"Diamandis","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_4","first-page":"256","article-title":"Cancer biomarker discovery and validation","volume":"4","author":"Goossens","year":"2015","journal-title":"Transl. Cancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update","volume":"36","author":"Wolff","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djr393","article-title":"Assessment of Ki67 in breast cancer: Recommendations from the international Ki67 in breast cancer working group","volume":"103","author":"Dowsett","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"Paik","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1373\/clinchem.2005.059832","article-title":"Serum tumor markers in breast cancer","volume":"52","author":"Duffy","year":"2006","journal-title":"Clin. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S1470-2045(20)30444-7","article-title":"Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): A multicentre, multicohort, phase 2a, platform trial","volume":"21","author":"Turner","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2203690","article-title":"Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer","volume":"387","author":"Modi","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"155572","DOI":"10.1016\/j.prp.2024.155572","article-title":"MicroRNA-21 (miR-21) in breast cancer: From apoptosis dysregulation to therapeutic opportunities","volume":"262","author":"Syed","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/sj.onc.1210083","article-title":"miR-21-mediated tumor growth","volume":"26","author":"Si","year":"2007","journal-title":"Oncogene"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1261\/rna.1034808","article-title":"MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis","volume":"14","author":"Yan","year":"2008","journal-title":"RNA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrclinonc.2014.5","article-title":"Clinical relevance of circulating microRNAs","volume":"11","author":"Schwarzenbach","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"13663","DOI":"10.1021\/acs.analchem.4c02606","article-title":"Bimetallic Single-Atom Nanozyme-Based Electrochemical-Photothermal Dual-Function Portable Immunoassay with Smartphone Imaging","volume":"96","author":"Wang","year":"2024","journal-title":"Anal. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zubair, M., Wang, S., and Ali, N. (2021). Advanced Approaches to Breast Cancer Classification and Diagnosis. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.632079"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"35597","DOI":"10.1021\/acsami.7b11385","article-title":"Label-Free Electrochemical Sensing Platform for MicroRNA-21 Detection Using Thionine and Gold Nanoparticles Co-Functionalized MoS2 Nanosheet","volume":"9","author":"Zhu","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bios.2015.09.025","article-title":"A novel label-free electrochemical miRNA biosensor using methylene blue as redox indicator: Application to breast cancer biomarker miRNA-21","volume":"77","author":"Behpour","year":"2016","journal-title":"Biosens. Bioelectron."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bios.2017.10.050","article-title":"A ratiometric electrochemical biosensor for the exosomal microRNAs detection based on bipedal DNA walkers propelled by locked nucleic acid modified toehold mediate strand displacement reaction","volume":"102","author":"Zhang","year":"2018","journal-title":"Biosens. Bioelectron."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"20570","DOI":"10.1021\/acsami.6b05648","article-title":"Microfluidic Immuno-Biochip for Detection of Breast Cancer Biomarkers Using Hierarchical Composite of Porous Graphene and Titanium Dioxide Nanofibers","volume":"8","author":"Ali","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1021\/acsnano.3c00449","article-title":"Integrated SERS-Vertical Flow Biosensor Enabling Multiplexed Quantitative Profiling of Serological Exosomal Proteins in Patients for Accurate Breast Cancer Subtyping","volume":"17","author":"Su","year":"2023","journal-title":"ACS Nano"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bioelechem.2017.07.002","article-title":"DNA biosensors based on gold nanoparticles-modified graphene oxide for the detection of breast cancer biomarkers for early diagnosis","volume":"118","author":"Saeed","year":"2017","journal-title":"Bioelectrochemistry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bios.2017.11.013","article-title":"Capacitive aptasensor based on interdigitated electrode for breast cancer detection in undiluted human serum","volume":"102","author":"Arya","year":"2018","journal-title":"Biosens. Bioelectron."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bios.2017.08.035","article-title":"Gold nanoparticles superlattices assembly for electrochemical biosensor detection of microRNA-21","volume":"99","author":"Tian","year":"2018","journal-title":"Biosens. Bioelectron."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: Correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMra043186","article-title":"Trastuzumab\u2014Mechanism of action","volume":"357","author":"Hudis","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Yarden","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc1609","article-title":"ERBB receptors and cancer: The complexity of targeted inhibitors","volume":"5","author":"Hynes","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1091\/mbc.e08-02-0159","article-title":"MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths","volume":"19","author":"Sayed","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/sj.onc.1210856","article-title":"MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer","volume":"27","author":"Asangani","year":"2008","journal-title":"Oncogene"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Mechanism and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: Towards implementation of circulating tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1056\/NEJMoa1413513","article-title":"Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer","volume":"372","author":"Swain","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1158\/1078-0432.CCR-05-0636","article-title":"Diagnostic evaluation of HER-2 as a molecular target: An assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials","volume":"11","author":"Press","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jclinpath-2014-202571","article-title":"Updated UK recommendations for HER2 assessment in breast cancer","volume":"68","author":"Rakha","year":"2015","journal-title":"J. Clin. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"19127","DOI":"10.1074\/jbc.M110.216887","article-title":"Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer","volume":"286","author":"Gong","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10549-014-3079-3","article-title":"Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: A translational research project within the GeparQuinto trial","volume":"147","author":"Gade","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1373\/clinchem.2014.221341","article-title":"Circulating microRNA pitfalls","volume":"61","author":"Witwer","year":"2015","journal-title":"Clin. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1634\/theoncologist.3-4-237","article-title":"HER2 oncogene in breast cancer","volume":"3","author":"Ross","year":"1998","journal-title":"Oncologist"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1309\/AJCPIRL4GUVGK3YX","article-title":"HER2 heterogeneity affects trastuzumab responses and survival in patients with HER2-positive metastatic breast cancer","volume":"142","author":"Lee","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/modpathol.2012.36","article-title":"Intratumoral heterogeneity of HER2 gene amplification in breast cancer: Its clinicopathological significance","volume":"25","author":"Seol","year":"2012","journal-title":"Mod. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"611","DOI":"10.5858\/133.4.611","article-title":"Genetic heterogeneity in HER2 testing in breast cancer: Panel summary and guidelines","volume":"133","author":"Vance","year":"2009","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1200\/JCO.2005.03.4744","article-title":"HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial","volume":"24","author":"Perez","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jcmm.12236","article-title":"Methodological challenges in utilizing miRNAs as circulating biomarkers","volume":"18","author":"Moldovan","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1093\/nar\/gni178","article-title":"Real-time quantification of microRNAs by stem-loop RT-PCR","volume":"33","author":"Chen","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1373\/clinchem.2014.221366","article-title":"Considerations for digital PCR as an accurate molecular diagnostic tool","volume":"61","author":"Huggett","year":"2015","journal-title":"Clin. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/cr068107d","article-title":"Surface plasmon resonance sensors for detection of chemical and biological species","volume":"108","author":"Homola","year":"2008","journal-title":"Chem. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/acssensors.6b00763","article-title":"SPR biosensors in clinical analysis","volume":"2","author":"Masson","year":"2017","journal-title":"ACS Sens."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.trac.2008.11.012","article-title":"The application of quantum dots, gold nanoparticles and molecular switches to optical nucleic-acid diagnostics","volume":"28","author":"Algar","year":"2009","journal-title":"TrAC Trends Anal. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nmeth.1248","article-title":"Quantum dots versus organic dyes as fluorescent labels","volume":"5","author":"Grabolle","year":"2008","journal-title":"Nat. Methods"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Wang, J. (2006). Analytical Electrochemistry, Wiley.","DOI":"10.1002\/0471790303"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1039\/c002690p","article-title":"Graphene-based nanomaterials and their electrochemistry","volume":"39","author":"Pumera","year":"2010","journal-title":"Chem. Soc. Rev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1039\/b714449k","article-title":"Electrochemical biosensors","volume":"39","author":"Ronkainen","year":"2010","journal-title":"Chem. Soc. Rev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.trac.2007.12.004","article-title":"Aptamer-based biosensors","volume":"27","author":"Song","year":"2008","journal-title":"Trends Anal. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.biotechadv.2011.09.003","article-title":"Immobilization strategies","volume":"30","author":"Sassolas","year":"2012","journal-title":"Biotechnol. Adv."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"RNA selection","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1039\/B611455E","article-title":"Lab-on-a-chip devices for global health: Past studies and future opportunities","volume":"7","author":"Chin","year":"2007","journal-title":"Lab Chip"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Kudreyeva, L., Kanysh, F., Sarsenbayeva, A., Abu, M., Kamysbayev, D., and Kedelbayeva, K. (2025). HER-2-targeted electrochemical sensors for breast cancer diagnosis: Basic principles, recent advancements, and challenges. Biosensors, 15.","DOI":"10.3390\/bios15040210"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1093\/nar\/gkp482","article-title":"Imaging individual microRNAs in single cells","volume":"37","author":"Lu","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1038\/nprot.2007.313","article-title":"Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification","volume":"2","author":"Silahtaroglu","year":"2007","journal-title":"Nat. Protoc."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nmeth.1294","article-title":"miRNA in situ hybridization in formaldehyde and EDC-fixed tissues","volume":"6","author":"Pena","year":"2009","journal-title":"Nat. Methods"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.trac.2010.07.008","article-title":"Electrochemical biosensors in clinical analysis","volume":"29","author":"Justino","year":"2010","journal-title":"TrAC Trends Anal. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nature13118","article-title":"Microfluidics in biomedical research","volume":"507","author":"Sackmann","year":"2014","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41591-018-0316-z","article-title":"A guide to deep learning in healthcare","volume":"25","author":"Esteva","year":"2019","journal-title":"Nat. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3390\/s80314000","article-title":"Electrochemical biosensors\u2014Sensor principles","volume":"8","author":"Grieshaber","year":"2008","journal-title":"Sensors"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1158\/0008-5472.CAN-24-1271","article-title":"SNHG17 reprograms energy metabolism of breast cancer by activating mitochondrial DNA transcription","volume":"85","author":"Gao","year":"2025","journal-title":"Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1021\/cr100313v","article-title":"Localized SPR sensors","volume":"111","author":"Mayer","year":"2011","journal-title":"Chem. Rev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1021\/ed060p702","article-title":"Cyclic voltammetry","volume":"60","author":"Kissinger","year":"1983","journal-title":"J. Chem. Educ."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"993","DOI":"10.5858\/arpa.2023-0950-SA","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer","volume":"147","author":"Wolff","year":"2023","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1021\/acs.chemrev.6b00220","article-title":"Electrochemical methods for the analysis of clinically relevant biomolecules","volume":"116","author":"Labib","year":"2016","journal-title":"Chem. Rev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.trac.2015.03.006","article-title":"Recent developments in recognition elements for chemical sensors and biosensors","volume":"68","author":"Justino","year":"2015","journal-title":"TrAC Trends Anal. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1373\/49.10.1579","article-title":"Potential clinical utility of serum HER-2\/neu oncoprotein concentrations in patients with breast cancer","volume":"49","author":"Carney","year":"2003","journal-title":"Clin. Chem."},{"key":"ref_83","first-page":"2295","article-title":"C-erbB-2 oncoprotein in the sera and tissue of patients with breast cancer. Utility in prognosis","volume":"16","author":"Molina","year":"1996","journal-title":"Anticancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/bcr1783","article-title":"Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status","volume":"9","author":"Fehm","year":"2007","journal-title":"Breast Cancer Res."},{"key":"ref_85","unstructured":"Bard, A.J., and Faulkner, L.R. (2001). Electrochemical Methods: Fundamentals and Applications, Wiley. [2nd ed.]."},{"key":"ref_86","first-page":"285","article-title":"miR-34a and miR-21 as biomarkers in evaluating the response of chemo-radiotherapy in Egyptian breast cancer patients","volume":"15","author":"Shaban","year":"2022","journal-title":"J. Radiat. Res. Appl. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/SLA.0000000000005613","article-title":"Evaluating the role of circulating microRNAs to aid therapeutic decision making for neoadjuvant chemotherapy in breast cancer: A prospective, multicenter clinical trial","volume":"276","author":"Davey","year":"2022","journal-title":"Ann. Surg."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ymeth.2012.09.015","article-title":"Assessing sample and miRNA profile quality in serum and plasma or other biofluids","volume":"59","author":"Blondal","year":"2013","journal-title":"Methods"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Kirschner, M.B., Kao, S.C.H., Edelman, J.J., Armstrong, N.J., Vallely, M.P., van Zandwijk, N., and Reid, G. (2011). Haemolysis during sample preparation alters microRNA content of plasma. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024145"},{"key":"ref_90","unstructured":"ClinicalTrials.gov (2021). Pre-Operative SABR with and Without Caloric Restriction for Early Stage Breast Cancer (NCT04959474)."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/XCS.0000000000000465","article-title":"Evaluating the role of circulating microRNAs in predicting long-term survival outcomes in breast cancer: A prospective, multicenter clinical trial","volume":"236","author":"Davey","year":"2023","journal-title":"J. Am. Coll. Surg."},{"key":"ref_92","unstructured":"ClinicalTrials.gov (2024). Studying the Role of Key Epigenetic Mediators in Breast Cancer Patients (NCT06759714)."},{"key":"ref_93","unstructured":"ClinicalTrials.gov (2021). Circulating MicroRNA 21 Expression Level Before and After Neoadjuvant Systemic Therapy in Breast Carcinoma (NCT05151224)."},{"key":"ref_94","unstructured":"ClinicalTrials.gov (2012). Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer (MIRHO; NCT01612871)."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"101126","DOI":"10.1016\/j.drup.2024.101126","article-title":"crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer","volume":"77","author":"Zou","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/s41388-018-0178-3","article-title":"miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy","volume":"37","author":"Xi","year":"2018","journal-title":"Oncogene"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"King, H.W., Michael, M.Z., and Gleadle, J.M. (2012). Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-421"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1158\/0008-5472.CAN-15-1625","article-title":"Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype","volume":"76","author":"Li","year":"2016","journal-title":"Cancer Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"19592","DOI":"10.18632\/oncotarget.14752","article-title":"Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer","volume":"8","author":"Donnarumma","year":"2017","journal-title":"Oncotarget"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"217794","DOI":"10.1016\/j.canlet.2025.217794","article-title":"Preferential release of microRNAs via extracellular vesicles is associated with ductal carcinoma in situ to invasive breast cancer progression","volume":"625","author":"Elayapillai","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_102","unstructured":"ClinicalTrials.gov (2021). Aberrant Expression of Micro RNA for Diagnosis of Breast Cancer (NCT04720508)."},{"key":"ref_103","unstructured":"ClinicalTrials.gov (2021). MicroRNA Profiles in Triple Negative Breast Cancer (TARMAC; NCT04771871)."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.22.02864","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: ASCO\u2013College of American Pathologists guideline update","volume":"41","author":"Wolff","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Wang, Y., Zhang, Y., Pan, C., Ma, F., and Zhang, S. (2015). Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: A meta-analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0118647"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/19\/3179\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:46:21Z","timestamp":1790761581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/19\/3179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":105,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["diagnostics16193179"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16193179","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]}}}